Clinical Pharmacology and Therapeutic Potential of Monoclonal Antibody Treatment in Rheumatoid Arthritis

被引：0
|
作者：
Ernest H. S. Choy
机构：
[1] Guy’s and King’s College Hospitals,Rheumatology Unit
[2] Guy’s Hospital,Rheumatology Unit, 5th Floor, Thomas Guy House
来源：
Drugs & Aging | 1998年 / 12卷
关键词：
Rheumatoid Arthritis; Adis International Limited; Synovial Fluid; Rheumatol; Synovial Joint;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Many monoclonal antibodies (mAb) have been tested in rheumatoid arthritis (RA). Murine antibodies were antigenic and caused human antimouse responses in the recipients. As a result, re-treatments were less effective and were associated with an increased risk of anaphylaxis. Advances in biotechnology have allowed us to develop chimaeric and humanised mAb that are less antigenic than their murine equivalents.
引用
收藏
页码：139 / 148
页数：9
相关论文
共 50 条
  • [1] Clinical pharmacology and therapeutic potential of monoclonal antibody treatment in rheumatoid arthritis
    Choy, EHS
    DRUGS & AGING, 1998, 12 (02) : 139 - 148
  • [2] Human monoclonal antibody treatment for rheumatoid arthritis
    不详
    BRITISH JOURNAL OF OPHTHALMOLOGY, 1999, 83 (04) : 389 - 389
  • [3] MONOCLONAL-ANTIBODY TREATMENT IN RHEUMATOID-ARTHRITIS - THE CLINICAL AND IMMUNOLOGICAL EFFECTS OF A CD7 MONOCLONAL-ANTIBODY
    KIRKHAM, BW
    PITZALIS, C
    KINGSLEY, GH
    CHIKANZA, IC
    SABHARWAL, S
    BARBATIS, C
    GRAHAME, R
    GIBSON, T
    AMLOT, PL
    PANAYI, GS
    BRITISH JOURNAL OF RHEUMATOLOGY, 1991, 30 (06): : 459 - 463
  • [4] HUMANIZED MONOCLONAL-ANTIBODY TREATMENT IN RHEUMATOID-ARTHRITIS
    KYLE, V
    RODDY, J
    HALE, G
    HAZLEMAN, BL
    WALDMANN, H
    JOURNAL OF RHEUMATOLOGY, 1991, 18 (11) : 1737 - 1738
  • [5] Interleukin-20 antibody is a potential therapeutic for rheumatoid arthritis
    Hsu, Yu-Hsiang
    Chang, Ming-Shi
    DRUG METABOLISM REVIEWS, 2011, 43 : 49 - 50
  • [6] Monoclonal antibody therapy in rheumatoid arthritis
    Choy, EHS
    Kingsley, GH
    Panayi, GS
    BRITISH JOURNAL OF RHEUMATOLOGY, 1998, 37 (05): : 484 - 490
  • [7] Monoclonal antibody treatments for rheumatoid arthritis
    Bossaller, Lukas
    Rothe, Achim
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (09) : 1257 - 1272
  • [8] Monoclonal antibody therapy in rheumatoid arthritis
    Kalden, JR
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 2005, 55 (11): : 700 - 700
  • [9] Clinical pharmacology of filgotinib in the treatment of rheumatoid arthritis: current insights
    Raimondo, Maria Gabriella
    Biggioggero, Martina
    Coletto, Lavinia Agra
    Ramming, Andreas
    Caporali, Roberto
    Favalli, Ennio Giulio
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2021, 14 (06) : 661 - 670
  • [10] The clinical pharmacology of therapeutic monoclonal antibodies
    Roskos, LK
    Davis, CG
    Schwab, GM
    DRUG DEVELOPMENT RESEARCH, 2004, 61 (03) : 108 - 120
12345